• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常的抗原加工和呈递:导致强直性脊柱炎免疫激活的关键致病因素。

Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis.

机构信息

Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.

Spondylitis Program, University Health Network, Toronto, Ontario, Canada.

出版信息

Semin Immunopathol. 2021 Apr;43(2):245-253. doi: 10.1007/s00281-020-00833-w. Epub 2021 Feb 2.

DOI:10.1007/s00281-020-00833-w
PMID:33532928
Abstract

The strong association of HLA-B27 with ankylosing spondylitis (AS) was first reported nearly 50 years ago. However, the mechanistic link between HLA-B27 and AS has remained an enigma. While 85-90% of AS patients possess HLA-B27, majority of HLA-B27 healthy individuals do not develop AS. This suggests that additional genes and genetic regions interplay with HLA-B27 to cause AS. Previous genome-wide association studies (GWAS) identified key genes that are distinctively expressed in AS, including the Endoplasmic Reticulum Aminopeptidase (ERAP) 1 and ERAP2. As these gene-encoding molecules are primarily implicated in the process of peptide processing and presentation, potential pathological interaction of these molecules with HLA-B27 may operate to cause AS by activating downstream immune responses. The aberrant peptide processing also gives rise to the accumulation of unstable protein complex in endoplasmic reticulum (ER), which drives endoplasmic reticulum-associated protein degradation (ERAD) and unfolded protein response (UPR) and activates autophagy. In this review, we describe the current hypotheses of AS pathogenesis, focusing on antigen processing and presentation operated by HLA-B*27 and associated molecules that may contribute to the disease initiation and progression of AS.

摘要

HLA-B27 与强直性脊柱炎(AS)的强关联最早在近 50 年前被报道。然而,HLA-B27 与 AS 之间的机制联系仍然是个谜。虽然 85-90%的 AS 患者携带 HLA-B27,但大多数 HLA-B27 健康个体不会发展为 AS。这表明其他基因和遗传区域与 HLA-B27 相互作用导致 AS。先前的全基因组关联研究(GWAS)确定了在 AS 中具有独特表达的关键基因,包括内质网氨肽酶(ERAP)1 和 ERAP2。由于这些编码分子主要参与肽加工和呈递过程,这些分子与 HLA-B27 的潜在病理性相互作用可能通过激活下游免疫反应导致 AS。异常的肽加工还导致内质网(ER)中不稳定蛋白复合物的积累,这驱动内质网相关蛋白降解(ERAD)和未折叠蛋白反应(UPR),并激活自噬。在这篇综述中,我们描述了 AS 发病机制的当前假说,重点介绍了 HLA-B*27 及其相关分子介导的抗原加工和呈递,这些可能有助于 AS 的发病和进展。

相似文献

1
Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis.异常的抗原加工和呈递:导致强直性脊柱炎免疫激活的关键致病因素。
Semin Immunopathol. 2021 Apr;43(2):245-253. doi: 10.1007/s00281-020-00833-w. Epub 2021 Feb 2.
2
The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.HLA - B27与内质网氨肽酶1/内质网氨肽酶2之间的相互作用:从抗病毒保护到脊柱关节炎
Clin Exp Immunol. 2017 Dec;190(3):281-290. doi: 10.1111/cei.13020. Epub 2017 Aug 30.
3
Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis.内质网氨肽酶在强直性脊柱炎发病机制中的作用。
Rheumatology (Oxford). 2015 Sep;54(9):1549-56. doi: 10.1093/rheumatology/kev218. Epub 2015 Jun 11.
4
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia.内质网氨肽酶基因间区的 rs75862629 次要等位基因影响人类白细胞抗原 B27 的表达,并保护撒丁岛的强直性脊柱炎患者。
Rheumatology (Oxford). 2019 Dec 1;58(12):2315-2324. doi: 10.1093/rheumatology/kez212.
5
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA-B27 Activates the Unfolded Protein Response.简报:内质网氨肽酶 2 与 HLA-B27 的功能相互作用激活未折叠蛋白反应。
Arthritis Rheumatol. 2017 May;69(5):1009-1015. doi: 10.1002/art.40033.
6
Ankylosing Spondylitis: A Trade Off of HLA-B27, ERAP, and Pathogen Interconnections? Focus on Sardinia.强直性脊柱炎:HLA-B27、ERAP 和病原体相互关系的权衡?关注撒丁岛。
Front Immunol. 2019 Jan 25;10:35. doi: 10.3389/fimmu.2019.00035. eCollection 2019.
7
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.ERAP1 与 HLA-B27 在强直性脊柱炎中的相互作用提示肽处理在 HLA-B27 疾病易感性机制中的作用。
Nat Genet. 2011 Jul 10;43(8):761-7. doi: 10.1038/ng.873.
8
ERAP1 and ankylosing spondylitis.内质网氨基肽酶 1 与强直性脊柱炎。
Curr Opin Immunol. 2013 Feb;25(1):97-102. doi: 10.1016/j.coi.2012.11.002.
9
Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).强直性脊柱炎相关内质网氨肽酶 2(ERAP2)对天然 HLA-B*27:05 配体组的调控
Mol Cell Proteomics. 2020 Jun;19(6):994-1004. doi: 10.1074/mcp.RA120.002014. Epub 2020 Apr 7.
10
HLA-B27 misfolding and ankylosing spondylitis.HLA-B27 错误折叠与强直性脊柱炎。
Mol Immunol. 2014 Jan;57(1):44-51. doi: 10.1016/j.molimm.2013.07.013. Epub 2013 Aug 30.

引用本文的文献

1
Single-cell immunomics reveals the immunological hallmarks about the onset and different outcomes for ankylosing spondylitis patients.单细胞免疫组学揭示了强直性脊柱炎患者发病及不同预后的免疫学特征。
Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07549-y.
2
Recent Advances in the Immunopathology of Axial Spondyloarthritis: with and without HLA-B27.轴性脊柱关节炎免疫病理学的最新进展:伴和不伴 HLA - B27
Curr Rheumatol Rep. 2025 Jun 21;27(1):27. doi: 10.1007/s11926-025-01194-9.
3
JAK inhibition and axial spondyloarthritis: new steps on the path to understanding pathophysiology.

本文引用的文献

1
Association of ERAP2 polymorphisms in Colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation: axial or peripheral predominance.哥伦比亚 HLA - B27+ 或 HLA - B15+ 脊柱关节炎患者中 ERAP2 基因多态性的关联及其与临床表现的关系:轴向或外周优势
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001250.
2
Autophagy dysfunction may be involved in the pathogenesis of ankylosing spondylitis.自噬功能障碍可能参与强直性脊柱炎的发病机制。
Exp Ther Med. 2020 Oct;20(4):3578-3586. doi: 10.3892/etm.2020.9116. Epub 2020 Aug 7.
3
Bone formation in axial spondyloarthritis: Is disease modification possible?
JAK抑制与轴性脊柱关节炎:理解病理生理学道路上的新进展
Front Immunol. 2025 Mar 4;16:1488357. doi: 10.3389/fimmu.2025.1488357. eCollection 2025.
4
Impact of endoplasmic reticulum aminopeptidases 1 (ERAP1) and 2 (ERAP2) on neutrophil cellular functions.内质网氨肽酶1(ERAP1)和2(ERAP2)对中性粒细胞细胞功能的影响。
Front Cell Dev Biol. 2025 Jan 7;12:1506216. doi: 10.3389/fcell.2024.1506216. eCollection 2024.
5
Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis - SPARTAN 2024 Annual Meeting Proceedings.年度回顾:脊柱关节炎发病机制的新见解——2024年斯巴达年会会议记录
Curr Rheumatol Rep. 2024 Dec 28;27(1):9. doi: 10.1007/s11926-024-01176-3.
6
Regulation mechanisms of disulfidptosis-related genes in ankylosing spondylitis and inflammatory bowel disease.强直性脊柱炎和炎症性肠病中与二硫键介导的程序性坏死相关基因的调控机制
Front Immunol. 2024 Feb 16;15:1326354. doi: 10.3389/fimmu.2024.1326354. eCollection 2024.
7
Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review-2023 SPARTAN Meeting Proceedings.轴性脊柱关节炎发病机制中的事件序列:2023 年 SPARTAN 会议记录的当前综述。
Curr Rheumatol Rep. 2024 Apr;26(4):133-143. doi: 10.1007/s11926-024-01136-x. Epub 2024 Feb 7.
8
Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis.与强直性脊柱炎免疫细胞浸润相关的新型自噬相关血液生物标志物
Pharmgenomics Pers Med. 2023 Dec 5;16:1055-1066. doi: 10.2147/PGPM.S428035. eCollection 2023.
9
Updates on ankylosing spondylitis: pathogenesis and therapeutic agents.强直性脊柱炎的最新进展:发病机制与治疗药物
J Rheum Dis. 2023 Oct 1;30(4):220-233. doi: 10.4078/jrd.2023.0041. Epub 2023 Sep 6.
10
Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by comprehensive bioinformatics analysis and molecular docking.通过综合生物信息学分析和分子对接技术探索强直性脊柱炎中枢纽炎性细胞焦亡相关基因、分子亚型和潜在药物。
BMC Musculoskelet Disord. 2023 Jun 29;24(1):532. doi: 10.1186/s12891-023-06664-8.
轴向型脊柱关节炎的骨形成:疾病缓解是否可能?
Best Pract Res Clin Rheumatol. 2019 Dec;33(6):101491. doi: 10.1016/j.berh.2020.101491. Epub 2020 Apr 15.
4
mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation and .雷帕霉素通过 mTOR 阻断在脊柱关节炎中的作用:对炎症和新骨形成的影响
Front Immunol. 2020 Feb 27;10:2344. doi: 10.3389/fimmu.2019.02344. eCollection 2019.
5
Impaired T cell receptor signaling and development of T cell-mediated autoimmune arthritis.T 细胞受体信号转导受损与 T 细胞介导的自身免疫性关节炎的发生。
Immunol Rev. 2020 Mar;294(1):164-176. doi: 10.1111/imr.12841. Epub 2020 Jan 16.
6
Ankylosing spondylitis: etiology, pathogenesis, and treatments.强直性脊柱炎:病因、发病机制及治疗方法
Bone Res. 2019 Aug 5;7:22. doi: 10.1038/s41413-019-0057-8. eCollection 2019.
7
Comparison of HLA-B*27 subtypes between Chinese patients with ankylosing spondylitis and non-ankylosing spondylitis carriers.中国强直性脊柱炎患者与非强直性脊柱炎携带者之间HLA - B*27亚型的比较。
J Int Med Res. 2019 Jul;47(7):3171-3178. doi: 10.1177/0300060519853929. Epub 2019 Jun 10.
8
exploits HLA-B27 and host unfolded protein responses to promote intracellular replication.利用 HLA-B27 和宿主未折叠蛋白反应来促进细胞内复制。
Ann Rheum Dis. 2019 Jan;78(1):74-82. doi: 10.1136/annrheumdis-2018-213532. Epub 2018 Oct 24.
9
HLA class I and II alleles in susceptibility to ankylosing spondylitis.HLA Ⅰ类和Ⅱ类等位基因与强直性脊柱炎的易感性。
Ann Rheum Dis. 2019 Jan;78(1):66-73. doi: 10.1136/annrheumdis-2018-213779. Epub 2018 Oct 19.
10
Mechanism and medical implications of mammalian autophagy.哺乳动物自噬的机制与医学意义。
Nat Rev Mol Cell Biol. 2018 Jun;19(6):349-364. doi: 10.1038/s41580-018-0003-4.